Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Saturday, May 29, 2010

Consolidation - the end of the big pharma model?

http://www.wikinvest.com/stock/Pfizer_(PFE)/Data/Market_Capitalization/2000 Explore more PFE Data at Wikinvest Since the year 2000, wha...

Sunday, May 23, 2010

Skin No. 3 - the FNIH

Sometime in early March, the FDA let it be known through the Infectious Diseases Society and others that they no longer knew how to set a no...

Saturday, May 15, 2010

Antibiotics - choosing a career.

Why did I leave the security of academia to work in the pharmaceutical industry? I get this question a lot, especially from students an...

Monday, May 10, 2010

Life in Big Pharma

In October 2001 I was the Vice President for Infectious Diseases and Co-leader (with a marketing colleague) of the anti-infectives therap...

Sunday, May 2, 2010

Treatment of Cancer vs. Antibiotics for Infection

I see that the first therapeutic vaccine for cancer was approved recently ( http://www.nytimes.com/2010/04/30/health/30drug.html ). Thi...

Friday, April 23, 2010

Tigecycline Bittersweet

I recently attended a large infectious diseases meeting in Europe. There I saw a booth advertising for “Pfizer’s” tigecycline. On my ...

Saturday, April 17, 2010

Paying the piper

One of the major problems in the fight against antibiotic resistance is how we will pay for the required solutions. Even though we stan...

View web version

Powered by Blogger.